Expressions of COX-2 Protein, C-erbB-2, P53 and VEGF-C Protein in Breast Cancer Tissues and Their Relationships with Clinicopathological Parameters and Prognosis
LI Ruiqing, ZHANG Jie
The Affiliated Hospital of Yangzhou University, Jiangsu Yangzhou 225000, China
Abstract：Objective: To analyze the expressions of cyclooxygenase-2 (COX-2) protein, human epidermal growth factor receptor 2 (c-erbB-2), mutant P53 protein, and vascular endothelial growth factor c (VEGF-C) protein in breast cancer tissues and their relationships with clinicopathological parameters and prognosis. Methods: The surgical resection specimens of 103 patients with breast cancer who were treated in the hospital from March 2017 to May 2019 were selected. The protein positive rates of COX-2, c-erbB-2, P53 and VEGF-C were determined by immunohistochemistry. The relationships of levels of the above indicators with pathological parameters such as TNM staging and differentiation degree were compared. The survival data of patients at 3 years after surgery were followed up, and Kaplan-Meier method was used to analyze the effects of protein levels of COX-2, c-erbB-2, P53 and VEGF-C on the prognosis survival. Results: TNM staging and differentiation degree were correlated with positive COX-2 (P<0.05). Tumor diameter ≥3cm and lymph node metastasis were associated with positive c-erbB-2 (P<0.05). TNM staging, differentiation degree and lymph node metastasis were correlated with positive P53 (P<0.05). Lymph node metastasis was related to positive VEGF-C (P<0.05). 103 patients were followed up for 3 years, with a follow-up rate of 100%; 20 patients died (19.42%) and 83 patients survived (80.58%) as of May 2022; positive patients were divided into survival and death subgroups according to the death status, and the histochemical scores of patients in the death subgroup were significantly higher than those in the survival subgroup at enrollment (P<0.05). Log-rank χ2 test showed that there were statistical differences in the cumulative survival rates between patients with positive and negative P53 and VEGF-C after 3 years of follow-up (χ2=14.000, 5.206, all P<0.05). There were no statistically significant differences in the cumulative survival rates between patients with positive and negative COX-2 and c-erbB-2 (χ2=1.761, 2.830, P=0.184, 0.093). Conclusion: The protein positive rates of COX-2, c-erbB-2, P53 and VEGF-C in breast cancer tissues are related to TNM staging, lymph node metastasis, differentiation degree and other pathological parameters, and they have certain guiding significance on the evaluation of prognosis of patients.
李瑞青, 张杰. 乳腺癌组织COX-2蛋白 c-erbB-2 P53 VEGF-C蛋白表达及其与临床病理参数和预后的关系[J]. 河北医学, 2023, 29(5): 747-751.
LI Ruiqing, ZHANG Jie. Expressions of COX-2 Protein, C-erbB-2, P53 and VEGF-C Protein in Breast Cancer Tissues and Their Relationships with Clinicopathological Parameters and Prognosis. HeBei Med, 2023, 29(5): 747-751.
[1] Cao W,Chen HD,Yu YW,et a.Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J].Chin Med (Engl),2021,134(7):783-791. [2] 周斌,刘世伟,高国璇,等.2016年NCCN乳腺癌临床实践指南(第1版)更新与解读[J].中国实用外科杂志,2016,36(10):1066-1072. [3] Ran Z,Hou L,Guo H,et al.Expression of VEGF,COX-2 and MMP-9 in breast cancer and their relationship with ultrasound findings[J].Int Clin Exp Pathol,2018,11(9):4264-4269. [4] De Souza C P,Alves B,Waisberg J,et al.Detection of COX-2 in liquid biopsy in patients with breast cancer[J].Journal of Clinical Pathology,2020,73(12):826-829. [5] 陈江,方孙阳,吴志明.JAM-A、p53和Ki67在乳腺癌组织中的表达及其临床意义[J].现代肿瘤医学,2020,28(19):3365-3369. [6] Thammineni KL,Thakur GK,Kaur N,et al.Significance of MMP-9 and VEGF-C expression in north indian women with breast cancer diagnosis[J].Mol Cell Biochem,2019,457(1-2):93-103. [7] 李永富,唐文军,李琴.血浆纤维蛋白原水平与乳腺癌组织p53蛋白表达的关系[J].中华内分泌外科杂志,2020,14(4):315-320. [8] Zhang YQ,Chen WL,Zhang F,et al.Over-expression of both VEGF-C and Twist predicts poor prognosis in human breast cancer[J].Clin Transl Oncol,2019,21(9):1250-1259.
2023, Vol. 29 
冀公网安备13080202000677号